Please use this identifier to cite or link to this item:
https://cuir.car.chula.ac.th/handle/123456789/14572
Title: | Genomic-based discovery and validation of novel anti-filarial drugs |
Authors: | Alisa Junpee Surang Nuchprayoon |
Email: | Alisa.J@student.chula.ac.th Surang.N@Chula.ac.th |
Other author: | Chulalongkorn University. Faculty of Medicine Chulalongkorn University. Faculty of Medicine |
Subjects: | Genomics Lymphatics--Diseases |
Issue Date: | 2007 |
Publisher: | Chulalongkorn University |
Citation: | Asian biomedicine : research, reviews and news. 1,4(December 2007): 327-344 |
Abstract: | Objective: This article reviews recent advances in filarial parasite genomics and opportunities for new antifilarial drug research. Methods and results: Genomic approach to filarial parasites provides new prospects for target validation. Comparative genomics filters enable us to select filarial parasite-specific gene products of interest. Functional genomics filters allow the selection of gene products essential for pathogen survival. The validated targets could be prioritized and categorized by informatics methods and manual curation. Conclusion: Lymphatic filariasis and onchocerciasis can be eliminated by either sterilizing or killing adult worms. It is most advantageous to target Wolbachia species for developing new drugs. Functional genomic approaches using microarrays, proteomics, and model organisms, have significantly expanded options for researchers. The genomic-based approach is promising for anti-filarial drug discovery in the future. |
URI: | http://cuir.car.chula.ac.th/handle/123456789/14572 |
ISSN: | 1905-7415 |
Type: | Article |
Appears in Collections: | Med - Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
article1.pdf | 355.93 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.